|
Eucalyptus Oil
|
D10.627.700.033 |
|
|
Artemether, Lumefantrine Drug Combination
|
D04.615.389.650.500 |
|
|
Lumefantrine
|
D04.615.389.650 |
|
|
Receptors, CCR2
|
D054390 |
[CCR receptors with specificity for CHEMOKINE CCL2 and several other CCL2-related chemokines. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; BASOPHILS; and NK CELLS.
] |
|
Drug Evaluation
|
E05.290.625 |
|
|
Chemokine CXCL13
|
D054382 |
[A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.
] |
|
Insulin Glargine
|
D06.472.699.587.200.300.100 |
|
|
Receptors, CXCR5
|
D054380 |
[CXCR receptors isolated initially from BURKITT LYMPHOMA cells. CXCR5 receptors are expressed on mature, recirculating B-LYMPHOCYTES and are specific for CHEMOKINE CXCL13.
] |
|
Weissella
|
B03.510.550.475.900 |
|
|
Leuconostocaceae
|
B03.510.550.475 |
|
|
Cryopyrin-Associated Periodic Syndromes
|
C16.320.382.500 |
|
|
Receptors, CXCR
|
D054387 |
[Chemokine receptors that are specific for CXC CHEMOKINES.
] |
|
Macronucleus
|
A11.284.430.106.550 |
|
|
Chlorpheniramine
|
D03.383.725.620.150 |
|
|
Pheniramine
|
D03.383.725.620 |
|
|
Receptors, CCR
|
D054388 |
[Chemokine receptors that are specific for CC CHEMOKINES.
] |
|
Adipokines
|
D06.472.699.042 |
|
|
Alginic Acid
|
D02.241.511.902.915.400.250 |
|
|
Receptors, CCR1
|
D054389 |
[CCR receptors with specificity for a broad variety of CC CHEMOKINES. They are expressed at high levels in MONOCYTES; tissue MACROPHAGES; NEUTROPHILS; and EOSINOPHILS.
] |
|
Cistus
|
B01.650.940.800.575.912.250.204.177 |
|
